주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Bio
목록
(
총 :
642 )
기사목록 보기 형태
제목형
요약형
포토형
US picks drugs targeted for price cuts. How will it affect Korean biosimilars?
Kim Chan-hyuk
2023.08.30 15:31
Liveome gets go-ahead for P1 clinical trial of microbiome drug in Australia
Kim Chan-hyuk
2023.08.30 11:32
Gencurix gets nod to sell lung cancer companion diagnostic test in Thailand
Kim Chan-hyuk
2023.08.30 11:28
Pharos iBio and Johns Hopkins partner in translational AML drug study
Kim Yoon-mi
2023.08.28 11:30
Seo eyeing 'Celltrion Holdings IPO' after completing merger of 3 major affiliates
Lee Han-soo
2023.08.25 15:53
More than 10 US insurers list Celltrion's Avastin biosimilar on formularies
Lee Han-soo
2023.08.23 10:04
Why did SK Biopharmaceuticals sell cenobamate’s Middle East, North Africa sales right for only ₩4 billion?
Kim Chan-hyuk
2023.08.18 15:09
Celltrion to absorb Celltrion Healthcare in strategic merger
Lee Han-soo
2023.08.17 16:06
FDA OKs GC Cell’s US affiliate for phase 1 study of NK cell therapy to treat lupus nephritis
Marianne Chang
2023.08.17 11:50
ISASS AP 2023 seeks international cooperation to advance spine surgery
Marianne Chang
2023.08.16 16:20
Cellivery faces delisting as it receives auditor’s ‘disclaimer of opinion’ for 1H
Kim Chan-hyuk
2023.08.16 12:30
Investment in bio and medical ventures halved in H1
Kim Chan-hyuk
2023.08.14 13:15
처음
이전
이전
이전
11
12
13
14
15
16
17
18
19
20
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기